merged_ftc-pharmacy-benefit-managers-drug-prices.txt
<question_number>1</question_number>
<answer>N/A</answer>
<other>The text does not mention that the FTC decided to bring a lawsuit against pharmacy benefit managers. It only mentions that the industry fears that the report could lead to a formal investigation or a lawsuit.</other>

<question_number>2</question_number>
<answer>N/A</answer>
<other>The text does not provide information on when CVS Health acquired Caremark.</other>

<question_number>3</question_number>
<answer>$1.6 billion</answer>
<other>The FTC report estimated that the practice of benefit managers paying their own pharmacies more than it would cost to buy generic cancer drugs from a wholesaler translated into nearly $1.6 billion in revenue over less than three years for the biggest three conglomerates.</other>